Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT00217451
Eligibility Criteria:
Inclusion Criteria:
* Uncomplicated P. falciparum malaria with acute manifestation
* Asexual parasitemia between 1,000-100,000/μL
* Body weight between 5-65 kg
* Ability to tolerate oral therapy
* Informed consent, oral agreement of the child if appropriate
* Residence in the study area for the duration of at least 4 weeks
Exclusion Criteria:
* Adequate anti-malarial treatment within the previous 7 days
* Antibiotic treatment for a concurrent infection
* Haemoglobin \<7g/dL
* Hematocrit \<25%
* Leukocyte count \>15,000/μL
* Mixed plasmodial infection
* Severe malaria, any other severe underlying disease
* Concomitant disease masking assessment of treatment response
* Inflammatory bowel disease, and any other disease causing fever.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
14 Years
Study:
NCT00217451
Study Brief:
Protocol Section:
NCT00217451